Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2695831000168111 | butyl hydroxybenzoate 10 mg / 1 g + salicylic acid 40 mg / 1 g + sodium propionate 2 mg / 1 g powder, 75 g (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2695841000168119 | salicylic acid 4% + butyl hydroxybenzoate 1% + sodium propionate 0.2% powder, 75 g | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| salicylic acid 4% + butyl hydroxybenzoate 1% + sodium propionate 0.2% powder, 75 g | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| salicylic acid 4% + butyl hydroxybenzoate 1% + sodium propionate 0.2% powder, 75 g | has MPUU | salicylic acid 4% + butyl hydroxybenzoate 1% + sodium propionate 0.2% powder | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Mycoderm powder, 75 g | Is a | True | salicylic acid 4% + butyl hydroxybenzoate 1% + sodium propionate 0.2% powder, 75 g | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR